IMP
Process View
positive regulation of triglyceride metabolic process
Any process that increases the frequency, rate or extent of the chemical reactions and pathways involving triglyceride, any triester of glycerol.
Loading network...
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "positive regulation of triglyceride metabolic process"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| CDK2 | cyclin-dependent kinase 2 | 1.000 | Yeast | |
| CCNA2 | cyclin A2 | 0.728 | ||
| DHCR7 | 7-dehydrocholesterol reductase | 0.717 | ||
| CCNE1 | cyclin E1 | 0.679 | ||
| APOE | apolipoprotein E | 0.426 | ||
| UHRF2 | ubiquitin-like with PHD and ring finger domains 2 | 0.258 | ||
| CCNB2 | cyclin B2 | 0.219 | ||
| CDT1 | chromatin licensing and DNA replication factor 1 | 0.200 | ||
| MED15 | mediator complex subunit 15 | 0.167 | ||
| HP | haptoglobin | 0.166 | ||
| SMPD1 | sphingomyelin phosphodiesterase 1, acid lysosomal | 0.163 | ||
| APOC1 | apolipoprotein C-I | 0.141 | ||
| CYP51A1 | cytochrome P450, family 51, subfamily A, polypeptide 1 | 0.131 | ||
| SKP2 | S-phase kinase-associated protein 2 (p45) | 0.124 | ||
| CTDNEP1 | CTD nuclear envelope phosphatase 1 | 0.106 | ||
| CCNB1 | cyclin B1 | 0.091 | ||
| ALB | albumin | 0.086 | ||
| CREBBP | CREB binding protein | 0.085 | ||
| TMEM188 | transmembrane protein 188 | 0.084 | ||
| AR | androgen receptor | 0.080 | ||
| RARA | retinoic acid receptor, alpha | 0.075 | ||
| SREBF2 | sterol regulatory element binding transcription factor 2 | 0.075 | ||
| KAT2B | K(lysine) acetyltransferase 2B | 0.072 | ||
| FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 0.066 | ||
| APOC3 | apolipoprotein C-III | 0.058 | ||
| MSTO1 | misato homolog 1 (Drosophila) | 0.046 | ||
| APOA1 | apolipoprotein A-I | 0.046 | Human | |
| CTNNB1 | catenin (cadherin-associated protein), beta 1, 88kDa | 0.045 | ||
| NCOA1 | nuclear receptor coactivator 1 | 0.043 | ||
| DHCR24 | 24-dehydrocholesterol reductase | 0.039 | ||
| APOA2 | apolipoprotein A-II | 0.037 | ||
| INSIG1 | insulin induced gene 1 | 0.035 | ||
| JUP | junction plakoglobin | 0.030 | ||
| UBE2R2 | ubiquitin-conjugating enzyme E2R 2 | 0.028 | ||
| LCAT | lecithin-cholesterol acyltransferase | 0.028 | ||
| FANCA | Fanconi anemia, complementation group A | 0.028 | ||
| NCOA6 | nuclear receptor coactivator 6 | 0.027 | ||
| NCAPH | non-SMC condensin I complex, subunit H | 0.023 | ||
| DYRK1A | dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A | 0.023 | ||
| PCSK9 | proprotein convertase subtilisin/kexin type 9 | 0.022 | ||
| CDK1 | cyclin-dependent kinase 1 | 0.022 | Yeast | |
| TNFRSF10C | tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain | 0.020 | ||
| FOXO3 | forkhead box O3 | 0.017 | ||
| HIC1 | hypermethylated in cancer 1 | 0.017 | ||
| FOXO1 | forkhead box O1 | 0.015 | ||
| NCOA2 | nuclear receptor coactivator 2 | 0.014 | ||
| HIF1A | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 0.014 | ||
| FGA | fibrinogen alpha chain | 0.014 | ||
| TNIK | TRAF2 and NCK interacting kinase | 0.014 | ||
| MVK | mevalonate kinase | 0.013 | ||
| NCAPD2 | non-SMC condensin I complex, subunit D2 | 0.012 | ||
| TXNDC2 | thioredoxin domain containing 2 (spermatozoa) | 0.012 | ||
| SKP1 | S-phase kinase-associated protein 1 | 0.012 | ||
| CDKN1A | cyclin-dependent kinase inhibitor 1A (p21, Cip1) | 0.012 | ||
| SCD | stearoyl-CoA desaturase (delta-9-desaturase) | 0.011 | ||
| PDIA3 | protein disulfide isomerase family A, member 3 | 0.011 | ||
| EDF1 | endothelial differentiation-related factor 1 | 0.011 | ||
| APOA4 | apolipoprotein A-IV | 0.010 | ||
| GLIS2 | GLIS family zinc finger 2 | 0.010 |